About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Fenofibrate Drug Reduces the Risk of Heart Disease in Type 2 Diabetes Patients

by Madhumathi Palaniappan on December 30, 2016 at 3:51 PM
Font : A-A+

Fenofibrate Drug Reduces the Risk of Heart Disease in Type 2 Diabetes Patients

Fenofibrate drug found to reduce the risk of cardiovascular events in patients with type 2 diabetes who have high levels of triglycerides and low levels of good cholesterol, finds a new study funded by the National Heart, Lung, and Blood Institute (NHLBI).

The research study is published in the journal JAMA Cardiology.

Advertisement


Fenofibrate is primarily used to help reduce elevated levels of triglycerides, or fat, in the blood. But the researchers wanted to know if the drug, when combined with statin treatment, could also reduce the risk of heart disease in people with type 2 diabetes. People with type 2 diabetes are at high risk of cardiovascular-related events, such as heart attacks, stroke, and even death, often because their levels of triglycerides are so high, and their high-density lipoprotein (HDL) cholesterol levels are low.

To answer their question, the researchers followed 4,640 participants from the NHLBI-funded Action to Control Cardiovascular Risk in Diabetes (ACCORD) Lipid Study for five years after the conclusion of the trial in 2009. The findings suggest that fenofibrate therapy may be beneficial in the way the researchers hoped: by reducing cardiovascular events in patients with type 2 diabetes who take statins but still have especially high triglycerides levels and low HDL cholesterol levels. However, a randomized study is needed to confirm these findings, according to the authors.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Diet and Oral Health: The Sugary Connection May Become Sour
World AIDS Day 2022 - Equalize!
Test Your Knowledge on Sugar Intake and Oral Health
View all
Recommended Reading
News Archive
Date
Category
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Diabetic Retinopathy Drug Toxicity Diabetes Diabetic Diet Otitis Media Diabetes - Essentials Diabetes - Self-Monitoring of Blood Glucose (SMBG) Insulin Delivery Devices Cardiac Catheterization Diabetes and Exercise 

Most Popular on Medindia

Find a Doctor Indian Medical Journals Hearing Loss Calculator Calculate Ideal Weight for Infants A-Z Drug Brands in India The Essence of Yoga Sanatogen Sinopril (2mg) (Lacidipine) How to Reduce School Bag Weight - Simple Tips Drug Side Effects Calculator
open close
ASK A DOCTOR ONLINE

×

Fenofibrate Drug Reduces the Risk of Heart Disease in Type 2 Diabetes Patients Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests